Hematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem CellsTransplantation ConditioningPeripheral Blood Stem Cell TransplantationTransplantation, HomologousMultiple MyelomaStem Cell TransplantationHematologic NeoplasmsTreatment OutcomeMelphalanCombined Modality TherapyDisease-Free SurvivalGraft vs Host DiseaseRetrospective StudiesLymphoma, Non-HodgkinSurvival RateBone Marrow TransplantationStem CellsGraft SurvivalAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsWhole-Body IrradiationHematopoietic Stem Cell MobilizationAntigens, CD34CyclophosphamideSalvage TherapyRecurrenceRemission InductionLiver TransplantationSurvival AnalysisTransplantation ChimeraHematopoiesisTissue DonorsImmunosuppressive AgentsBusulfanCord Blood Stem Cell TransplantationHistocompatibility TestingKidney TransplantationCell TransplantationLeukemiaBone Marrow CellsPrognosisHistocompatibilityAntineoplastic AgentsTime FactorsCell DifferentiationGranulocyte Colony-Stimulating FactorChimerismBone MarrowGraft vs Leukemia EffectMesenchymal Stem Cell TransplantationLeukemia, Myeloid, AcuteCell LineageColony-Forming Units AssayFlow CytometryMyelodysplastic SyndromesGraft vs Tumor EffectFollow-Up StudiesHematologic DiseasesTransplantation ImmunologyMice, Inbred C57BLStem Cell NicheHLA AntigensCells, CulturedAdult Stem CellsHeart TransplantationHepatic Veno-Occlusive DiseaseEtoposideTransplantation, IsogeneicCell SeparationVidarabineSiblingsGraft RejectionCytarabineFetal BloodLung TransplantationUnrelated DonorsHodgkin DiseaseLeukapheresisCarmustineOrgan TransplantationCell SurvivalBone Marrow PurgingSevere Combined ImmunodeficiencyLymphocyte TransfusionT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaEmbryonic Stem CellsTransplantationCell ProliferationBlood Transfusion, AutologousAcute DiseaseAnemia, AplasticCytomegalovirus InfectionsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAntilymphocyte SerumImmunosuppressionMesenchymal Stromal CellsDonor Selection